565-02-013 ISMRM Abstract

Diagnostic Efficacy of Contrast-Enhanced Subtraction MRI for Detecting Small Brain Metastases from Lung Cancer

Primary: Neuro - Tumors

Secondary: Contrast Mechanisms - Contrast Agents

565-02-013 · Neuro-Oncology and Ear, Nose, and Throat Cancer · Wednesday, 13 May, 9:15 AM–10:10 AM · Digital Posters Row F

Keywords: Brain Magnetic resonance imaging Metastasis Contrast-enhancement Subtraction

Accepted

Wei Lin ¹

¹Department of Radiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China

Presenting Author: Wei Lin

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. Zhang X, Yang J, Hu H, Wang Y, Zhang Z, Lv J, Li J. Longitudinal MRI evaluation of the efficacy of non-enhanced lung cancer brain metastases. Sci Rep. 2025 Jan 27;15(1):3318. doi: 10.1038/s41598-025-87422-9. [doi]

2. Downs RK, Bashir MH, Ng CK, Heidenreich JO. Quantitative contrast ratio comparison between T1 (TSE at 1.5T, FLAIR at 3T), magnetization prepared rapid gradient echo and subtraction imaging at 1.5T and 3T. Quant Imaging Med Surg. 2013 Jun;3(3):141-6. doi: 10.3978/j.issn.2223-4292.2013.05.02. [doi]

3. McKay MJ. Brain metastases: increasingly precision medicine-a narrative review. Ann Transl Med. 2021 Nov;9(21):1629. doi: 10.21037/atm-21-3665. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/565-02-013